Ultrahuman Adds Glucose Tracking Through Abbott Partnership

June 18, 2026

Ultrahuman, a smart ring maker focused on metabolic health, has launched M2 Live, a new glucose-tracking product that integrates Abbott’s over-the-counter Lingo continuous glucose monitor (CGM). This makes Ultrahuman one of the first platforms to partner with Lingo, which is designed for adults not on insulin who want to understand their overall health, including those with prediabetes. The product doesn’t require a prescription and will launch in the U.S. through Ultrahuman’s website in the coming weeks.

M2 Live streams glucose data from the Lingo app into the Ultrahuman app, providing continuous metabolic insights backed by Ultrahuman’s analytics engine and AI-powered metabolic scoring. Each Lingo biosensor can be worn for up to 14 days and is applied to the arm with only a slight sting during insertion.

Pricing starts at $129 for a single sensor, with a monthly subscription option at $99 that includes ongoing sensors and app access. The subscription is more cost-effective for users wanting continuous tracking, while the one-time sensor purchase offers flexibility for shorter-term use. Athletech News